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Abstract
Objective. The aim of this study was to compare clinical examination with power Doppler US (PDUS) in
the detection of entheseal abnormalities in patients with AS.
Methods. Thirty-six AS patients underwent clinical and PDUS examination of the following bilateral
entheseal sites: common extensor tendon at its insertion at the lateral humeral epicondyle; gluteus ten-
dons at their insertion at the greater trochanter; quadriceps tendon at its insertion at the superior pole of
the patella; patellar tendon at its proximal insertion at the inferior pole of the patella; patellar tendon at its
distal insertion at the tibial tuberosity; Achilles tendon at its insertion at the calcaneus; and plantar
aponeuroses at its insertion at the calcaneus.
Results. Clinical and PDUS examination revealed at least one abnormal enthesis in 23 (63.9%) and 35
(97.2%) AS patients, respectively. Furthermore, of 432 entheses examined in our 36 AS patients, 64
(14.8%) were considered abnormal by clinical examination and 192 (44.4%) by PDUS. US abnormalities
most commonly found were enthesophytes (31.7%), calcifications (33.7%), thickening (29.8%) and hypo-
echogenicity (26.6%). We found erosions and PD signals in 9.7 and 6% of examined entheseal sites,
respectively. The evidence of entheseal abnormalities by clinical examination has a poor likelihood ratio
(LR) for the presence of US abnormalities with vascularization (LR = 1.61), without vascularization
(LR = 1.24) or erosions (LR = 1.51) at all sites.
Conclusions. PDUS permits detection of structural and inflammatory abnormalities of the enthesis in AS
and may complement the physical examination in order to better evaluate enthesitis.
Key words: Power Doppler ultrasound, Enthesitis, Ankylosing spondylitis.
Introduction
Enthesitis, defined as inflammation of the origin and inser-
tion of ligaments, tendons, aponeuroses, annulus fibrosis
and joint capsules, is a hallmark of AS. In primary AS,
the frequency of peripheral enthesitis has been found to
be within 2558% [1], but the real prevalence of this fea-
ture depends on the type of assessment (i.e. clinical, ima-
ging or histological). Peripheral enthesitis is usually
revealed by clinical findings, such as localized pain,
tenderness and swelling. Nevertheless, there are no def-
inite clinical criteria for the diagnosis of this manifestation
that may even be asymptomatic. Histological examination
of the enthesis is the potential gold standard for evaluation
of enthesitis, but is rarely obtained due to ethical and
practical constraints. Imaging techniques include conven-
tional radiography, bone scintigraphy, MRI or US [1].
Conventional radiography may show erosions and bone
proliferation changes (ill-defined and finely speculated),
but only in more advanced phases [1]. Technetium-99 m
methylene diphosphonate scintigraphy has been shown
to be a sensitive indicator of heel enthesitis, but its spe-
cificity has not been determined. MRI may show the swel-
ling of the enthesis and the peritendinous soft tissue, the
distension of adjacent bursae by fluid collection and
oedema of the bone near the insertion. On the other
hand, the study of entheses with MRI is limited because
of its reduced availability and high costs [2], and also by
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the evidence that the normal features of the enthesis
cannot be recognized with conventional sequences [3].
US has proved to be a highly sensitive and non-invasive
tool to assess the presence of enthesitis, characterized by
hypoechogenicity with loss of tendon fibrillar pattern,
tendon thickening, local calcifications, enthesophytes
and bony erosions. Moreover, the use of power Doppler
US (PDUS) allows the detection of abnormal vasculariza-
tion of soft tissues in inflammatory articular diseases [4].
Entheseal involvement in SpA is not always detected by
clinical examination. US is better than clinical examination
for detecting entheseal abnormalities, but there is a con-
siderable discrepancy between clinical and US findings [5,
6]. It is unknown whether this discrepancy might be
related to the different abnormalities of the enthesis or
with the presence/absence of vascularization. The aim
of this study was to compare clinical examination with
PDUS in the detection of entheseal abnormalities in pa-
tients with AS.
Patients and methods
Thirty-six consecutive patients with AS (according to
the modified New York criteria) [7] referred to the
Rheumatology Unit at Sapienza University of Rome were
studied. Patients with previous joint surgery of the knee
or ankle, CS injection of the structures examined within
the previous 6 weeks or peripheral neuropathy were
excluded from the study. Informed consent was obtained
from each patient before inclusion in the study. The study
was approved by the ethics committee of the Universita`
degli Studi di Roma ‘La Sapienza’  Azienda Policlinico
Umberto I.
All patients underwent clinical and US examinations of
the following bilateral entheseal sites: common extensor
tendon at its insertion at the lateral humeral epicondyle;
gluteus tendons at their insertion at the greater trochanter;
quadriceps tendon at its insertion at the superior pole of
the patella; patellar tendon at its proximal insertion at the
inferior pole of the patella; patellar tendon at its distal in-
sertion at the tibial tuberosity; Achilles tendon at its inser-
tion at the calcaneus; and plantar aponeuroses at its
insertion at the calcaneus. Thus, a total of 432 entheses
were examined. Our study was conducted in compliance
with good clinical practice, following the routine monitor-
ing procedures performed in our unit for patients with
SpA.
Patients were initially assessed by a single rheumatolo-
gist who developed the clinical history (including potential
traumatic factors and professional activity) and performed
the physical examination, including clinical evaluation of
the enthesis. Clinical enthesopathy was defined by the
presence of at least one of the following findings: (i) spon-
taneous pain, (ii) tenderness elicited by pressure, mobil-
ization and contraction against resistance of the
corresponding tendons and (iii) local swelling of the
enthesis [6]. All patients underwent evaluation using the
BASMI [8], BASDAI [9], BASFI [10], HAQ [11], patient’s
and physician’s visual analogue scale (VAS) on global dis-
ease activity (0100 mm), ESR and CRP.
US assessment
Using a MyLab 70 XVG machine equipped with a broad-
band 618 linear probe, sonographic examination was
performed at the same entheseal sites clinically evaluated
by a rheumatologist experienced in musculoskeletal son-
ography (A.I.), who was unaware of the clinical findings. In
all cases the following settings were used: grey-scale fre-
quency 1215 MHz; Doppler frequency 6.77.5 MHz; PD
pulse repetition frequency 750 Hz; and low wall filters. At
the beginning of each scanning session at different enthe-
seal sites, the focus was positioned at the level of the
region of interest and the colour box that was enlarged
to the upper part of the image. Colour gain was adjusted
just below the level that caused the appearance of noise
artefacts [12].
Patients were asked to adopt the most appropriate pos-
ition that produced an optimal sonographic scan of the
various entheses. After having applied gel to the skin to
provide an acoustic interface, PDUS examinations were
carried out, paying attention not to apply probe pressure
on the anatomical structures under examination. In all
cases, both longitudinal and transverse scans were
performed, keeping the probe parallel and perpendicular,
respectively, to the tendon’s fibres.
During the same scanning session, PDUS was initially
performed in grey-scale modality with the aim of detecting
morphological changes, and immediately afterwards
using PD techniques to search for local abnormal vascu-
larization [6]. According to OMERACT [13] definitions of
enthesopathy, the following changes were registered: ten-
don hypoechogenicity at the level of its bony insertion;
tendon thickening at the level of its bony insertion; intra-
tendinous calcifications; enthesophytes; bony erosions at
the level of the enthesis; bony cortex irregularities at the
level of the enthesis; and the presence of Doppler signal at
the level of the bony insertion. Where present, intra-
tendinous Doppler signal, bursitis and both partial and
full-thickness tendon lesions were registered. All findings
had to be confirmed by two perpendicular planes.
Elementary US and PD findings were recorded as being
present, in accordance with the reported definitions in the
literature [5, 6, 14, 15], as follows: hypoechogenicity: loss
of the typical fibrillar pattern with appearance of local ex-
tended hypoechoic areas; thickening: tendon swelling at
the level of its bony insertion; calcification: hyperechoic
spot or linear formation; enthesophyte: step-up bony
prominence at the enthesisbone junction; bony erosion:
discontinuity of the bony surface visible in two perpen-
dicular planes; bony irregularity: change in the cortical
profile not including definite enthesophyte or bone ero-
sion; bursitis: abnormal hypoechoicanechoic intra-bursal
material that is displaceable and compressible; and
tendon lesions: interruption of the tendon fibres with or
without hypoechoic material filling the defect. All changes
were recorded according to an absentpresent criterion.
According to D’Agostino et al. [6], US enthesitis was
classified considering the different combinations of abnor-
mal grey-scale and/or PD features into the following five
distinctive patterns: Stage 1: vascularization at the cortical
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junction without abnormal findings in B mode; Stage 2a:
vascularization associated with swelling and/or decreased
echogenicity at the cortical junction in B mode; Stage 3a:
same as Stage 2a, plus erosions of cortical bone and/or
calcification of the enthesis, and optional surrounding bur-
sitis; Stage 2b: abnormal findings in B mode as in Stage
2a, but without vascularization; and Stage 3b: abnormal
findings in B mode as in Stage 3a, but without vascular-
ization. We considered Stages 2a and 2b suggestive of
inactive lesions [6].
Statistical analysis
Categorical variables were analysed by 2 test or Fisher’s
exact test. The results were presented as the median
(25th75th percentile) and the significance of the differ-
ences was determined using the MannWhitney test for
unpaired samples and Wilcoxon’s test for paired samples.
Sensitivity, specificity, likelihood ratio (LR), false-negative
(FNR) and false-positive rates (FPR) have been calculated
with 95% CI. Agreement was assessed using the wei-
ghted k-statistic (k= 0, no concordance; 0< k< 0.20,
slight concordance; 0.21< k< 0.40, fair concordance;
0.41< k< 0.60, moderate concordance; 0.61< k< 0.80,
substantial concordance; and 0.81< k< 1.00, perfect
concordance. Statistical significance was accepted at
P< 0.05.
Results
The main clinical and demographic features are shown in
Table 1. These features are not significantly different be-
tween patients treated with or without anti-TNF-a drugs.
In particular, patients treated with or without anti-TNF-a
drugs showed similar values (median/25th75th per-
centile) of BASDAI (4.6/2.56.2 vs 4.5/2.75.8; P= n.s.),
BASMI (4/14 vs 5/3.57; P= n.s.) and BASFI (32/1449
vs 42/2449; P= n.s.). Nineteen of 21 patients of the
anti-TNF-a group were treated for at least 12 weeks.
The extra-articular involvement included anterior uveitis
(n= 10), psoriasis (n= 2), psoriasis plus uveitis and IBD
(n= 1). Clinical and PDUS examination revealed at least
one abnormal enthesis in 23 (63.9%) and 35 (97.2%) AS
patients, respectively. Furthermore, of 432 entheses
examined in our 36 AS patients, 64 (14.8%) were
considered abnormal by clinical examination and
192 (44.4%) by PDUS. PDUS abnormalities of 432 exam-
ined entheseal sites are shown in Table 2.
Classification of abnormal peripheral enthesis features
by B-mode US combined with PD in AS patients is shown
in Table 3. The age (median/25th75th percentile) of pa-
tients showing PDUS abnormalities with vascularization
was significantly higher (57/5065 vs 46/40.554 years;
P< 0.005) than the age of patients showing PDUS
abnormalities without vascularization. These groups of
patients did not have any other differences in clinical or
laboratory findings. Comparison of clinical findings with
PDUS abnormalities (with or without vascularization) in
432 entheses of 36 AS patients is shown in Table 4.
Sensitivity, specificity, LR, FPR and FNR for the clinical
examination vs PDUS abnormalities as the gold standard
are shown in Table 5 (clinical examination vs PDUS
abnormalities with vascularization) and Table 6 (clinical
examination vs PDUS abnormalities without vasculariza-
tion). The sensitivity, specificity and LR of the clinical
examination for the presence of US erosions at all sites
were 0.21 (95% CI 0.10, 0.37), 0.85 (95% CI 0.81, 0.89)
and 1.51 (95% CI 0.81, 2.84), respectively. Values of k
(95% CI) between clinical examination and US abnormal-
ities with vascularization, PDUS abnormalities without
vascularization and US erosion were 0.05 (0, 0.24), 0.03
(0, 0.14) and 0.05 (0, 0.23), respectively. PDUS abnormal-
ities (with or without vascularization) were not significantly
different between patients treated with or without
anti-TNF-a drugs.
Discussion
The concept of entheses prone to pathological changes in
SpA is well recognized [3]. The relevant role of peripheral
enthesitis is supported by the evidence that this feature,
by clinical examination, has been included in the classifi-
cation criteria of Amor (heel pain or other well-defined
enthesopathic pain) [16], the ESSG [17] and the
Assessment in SpondyloArthritis International Society
(ASAS) for axial SpA [18].
Among imaging techniques, musculoskeletal US, by
using both grey-scale and PD modalities, has an increas-
ing and relevant role in the assessment of SpA, mainly for
its capacity to detect enthesitis that may be clinically
asymptomatic [5, 6, 19]. In the assessment of entheseal
involvement, PDUS has shown to provide the visualization
of abnormal vascularization and hyperaemia of soft
TABLE 1 Main clinical and demographic features of 36
patients with AS
Male/female, n 28/8
Age, mean (range), years 51.3 (2375)
Disease onset, mean
(range), years
35.4 (1565)
Disease duration, mean
(range), years
15.8 (243)
BASDAI 4.5 (2.46.1)a
Peripheral involvement, n (%) 14 (38.9)
Extra-articular involvement, n (%) 15 (41.7)
BASMI 4 (16)a
BASFI 35 (15.549.6)a
HAQ 0.8125 (0.341.03)a
VAS patient, mm 45 (2261)a
VAS physician, mm 47.5 (2360)a
ESR, mm/h 12 (727)a
CRP, mg/l 0.6 (0.212.87)a
Treatment, n/%
CSs 6/16.6
NSAIDs 22/61.1
DMARDs 4/11.1
Anti-TNF drugs 21/58.3
aMedian (25th75th percentile).
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TABLE 4 Comparison of clinical findings vs PDUS abnormalities with or without vascularization in 432 entheses of 36 AS
patients
Clinically positive enthesis (n=64) Clinically negative enthesis (n=368)
Entheseal site
Normal
by US,
n (%)a
US
abnormalities
with
vascularization,
n (%)a
US
abnormalities
without
vascularization,
n (%)a
Normal
by US,
n (%)b
US
abnormalities
with
vascularization,
n (%)b
US
abnormalities
without
vascularization,
n (%)b
Lateral epicondyle 3 (23.1) 3 (23.1) 7 (53.8) 27 (45.8) 7 (11.9) 25 (42.4)
Great trochanter 9 (56.2) 1 (6.2) 6 (37.5) 29 (51.8) 0 (0) 27 (48.2)
Quadriceps tendon 0 (0) 1 (33.3) 2 (66.6) 26 (37.7) 4 (5.8) 39 (56.5)
Tibial tuberosity 3 (37.5) 0 (0) 5 (62.5) 38 (59.4) 4 (6.2) 22 (34.4)
Achilles tendon 12 (63.1) 1 (5.3) 6 (31.6) 34 (64.1) 5 (9.4) 14 (26.4)
Plantar fascia 3 (60.0) 0 (0) 2 (40.0) 56 (83.6) 0 (0) 11 (16.4)
All sites 30 (46.8) 6 (9.3) 28 (43.7) 210 (57.1) 20 (5.4) 138 (37.5)
aThe percentage (%) value is calculated on the number of total positive entheseal sites by clinical examination. bThe percen-
tage (%) value is calculated on the number of total negative entheseal sites by clinical examination.
TABLE 2 PDUS abnormalities of 432 examined entheseal sites
Abnormalities
Sites
Lateral
epicondyle
Great
trochanter
Quadriceps
tendon
Tibial
tuberosity
Achilles
tendon
Plantar
fascia
All
sites
Enthesophytes, n (%) 20 (27.7) 11 (1.,3) 43 (59.7) 23 (31.9) 35 (48.6) 5 (6.9) 137 (31.7)
Calcifications, n (%) 30 (41.6) 54 (75.0) 32 (44.4) 18 (25.0) 5 (6.9) 7 (9.7) 146 (33.7)
Tendon lesion, n (%) 1 (1.4) 0 (0) 2 (2.7) 0 (0) 0 (0) 1 (1.4) 4 (0.9)
Erosions, n (%) 26 (36.1) 6 (8.3) 1 (1.4) 6 (8.3) 3 (4.2) 0 (0) 42 (9.7)
Bone irregularity, n (%) 12 (16.6 19 (26.4) 4 (5.6) 17 (23.6) 2 (2.7) 1 (1.4) 55 (12.7)
Hypoechogenicity, n (%) 37 (51.4) 22 (30.5) 37 (51.4) 16 (22.2) 10 (13.9) 7 (9.7) 129 (29.8)
Thickening, n (%) 12 (16.6) 12 (16.6) 21 (29.1) 23 (31.9) 20 (27.7) 10 (13.9) 98 (22.6)
Bursitis, n (%) 0 (0) 0 (0) 1 (1.4) 21 (29.1 10 (13.9) 0 (0) 32 (7.4)
PD at the level of bony insertion, n (%) 10 (13.9) 1 (1.4) 5 (6.9) 4 (5.6) 6 (8.3) 0 (0) 26 (6.0)
At least one PDUS abnormality, n (%) 42 (58.3) 34 (47.2) 46 (63.8) 31 (43.0) 26 (36.1) 13 (18.0) 192 (44.4)
At least one clinical abnormality, n (%) 13 (18.0) 16 (22.2) 3 (4.16) 8 (11.1) 19 (26.4) 5 (6.9) 64 (14.8)
TABLE 3 Classification, according to D’Agostino et al. [6], of entheseal peripheral abnormalities (n= 192) by PDUS in AS
patients
Abnormalities with vascularization Abnormalities without vascularization
Entheseal site
Stage 1,
n (%)
Stage 2a,
n (%)
Stage 3a,
n (%)
Total
(1+2a+3a),
n (%)
Stage 2b,
n (%)
Stage 3b,
n (%)
Total
(2b+3b),
n (%)
Lateral epicondyle 1 (1.4) 1 (1.4) 8 (11.1) 10 (13.9) 15 (20.1) 17 (23.6) 32 (44.4)
Great trochanter 1 (1.4) 0 (0) 0 (0) 1 (1.4) 23 (31.9) 10 (13.9) 33 (45.8)
Quadriceps tendon 2 (2.7) 0 (0) 3 (4.2) 5 (6.9) 14 (19.4) 27 (37.5) 41 (56.9)
Tibial tuberosity 0 (0) 0 (0) 4 (5.6) 4 (5.6) 10 (13.9) 17 (23.6) 27 (37.5)
Achilles tendon 1 (1.4) 1 (1.4) 4 (5.6) 6 (8.3) 5 (6.9) 15 (20.1) 20 (27.7)
Plantar fascia 0 (0) 0 (0) 0 (0) 0 (0) 11 (15.3) 2 (2.7) 13 (18.0)
All sites 5 (1.6) 2 (0.4) 19 (4.4) 26 (6.0) 78 (18.0) 88 (20.3) 166 (38.4)
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tissues [6, 19]. In particular, abnormal vascularization was
present only in the SpA patients, while this finding was not
observed in the healthy controls [6]. Moreover, PDUS has
been demonstrated to be more sensitive than physical
examination in the detection of enthesitis in AS, even
though there is a discrepancy between clinical and US
examinations [5, 6, 20]. In our study, the evidence of at
least one abnormality by PDUS in 97.2% of AS patients
and in 44% of all examined sites confirms previous results
[5, 6, 19, 20]. In fact, Balint et al. [5] found US abnormal-
ities in 56% of five entheseal sites of the lower limbs (su-
perior pole and inferior pole of patella, tibial tuberosity,
Achilles tendon and plantar aponeurosis) in 35 SpA pa-
tients (27 with AS). Lehtinen et al. [21] reported that enthe-
sopathic abnormalities were more frequently (66%) found
at the distal part of lower limbs (i.e. as patella insertion,
Achilles tendon and plantar fascia insertions) with respect
to the proximal part of lower limbs (i.e. ischial tuberosity,
great trochanter and insertion of adductor muscles) in
31 patients with SpA. Kiris et al. [22] showed that changes
in the grey scale combined with PD were more prevalent
in lower extremity entheses in a group of 30 AS patients.
Borman et al. [23] reported pathological US abnormalities
at insertions of the Achilles tendon and plantar fascia
on the calcaneum in 56.8% of 44 SpA patients, whereas
37% showed signs of entheseal involvement by clinical
examinations. D’Agostino et al. [6] reported that 161 (98%)
of 164 patients with SpA (104 patients with AS) had at
least one abnormal enthesis by grey scale combined with
PD. The sites most commonly affected were the distal por-
tions of the lower limbs (i.e. Achilles tendon, plantar fascia
and patellar tendon origin were abnormal in 79, 74 and
59%, respectively, of AS patients).
Why there is a predilection for the distal part of lower
limbs by the enthesitic process is unknown, but anatomic
and physiological factors, such as the major length of the
tendon, might play a role. In fact, the major length of the
Achilles tendon or its movement on the adjacent bursa
may be responsible of a more relevant mechanical injury
at this entheseal site [3, 6, 21]. Nevertheless, we fre-
quently found PDUS abnormalities both in upper and
lower limbs (Table 3). In particular, we found US abnorm-
alities in 58% of lateral epicondyle sites. Thus, in our
study, the evidence of frequent involvement of entheseal
sites localized in upper and lower limbs suggests that the
mechanical hypothesis should be applied at each different
site, considering its anatomic and physiologic features.
The role of stress or trauma in the pathogenesis of enthe-
sitis in SpA patients has been reviewed by Olivieri et al.
[24]. In fact, physical injury may trigger peripheral mani-
festations of SpA such as enthesitis [25] and dactylitis
[26], as well as arthritis [24]. The damage and repair at
the enthesis level in SpA could trigger an inflammatory
reaction and may regulate immune activation [27]. Thus
biomechanical stress factors can play a role in the patho-
genesis of both inflammatory and mechanical entheso-
pathies, but the effects of mechanical load can be
amplified in SpA, especially in HLA-B27-positive patients
TABLE 6 The sensitivity, specificity, LR, FPR and FNR of clinical examination for the presence of PDUS abnormalities
without vascularization
Entheseal site
Sensitivity
(95% CI)
Specificity
(95% CI) LR+ (95% CI) FPR (95% CI) FNR (95% CI)
Lateral epicondyle 0.21 (0.09, 0.40) 0.85 (0.69, 0.93) 1.45 (0.54, 3.91) 0.46 (0.20, 0.73) 0.42 (0.29, 0.55)
Great trochanter 0.18 (0.07, 0.36) 0.74 (0.57, 0.86) 0.7 (0.28, 1.74) 0.62 (0.35, 0.83) 0.48 (0.34, 0.61)
Quadriceps tendon 0.04 (0, 0.17) 0.96 (0.81, 0.99) 1.51 (0.14, 15.9) 0.33 (0.01, 0.87) 0.56 (0.44, 0.68)
Tibial tuberosity 0.18 (0.07, 0.38) 0.93 (0.80, 0.98) 2.77 (0.72, 10.7) 0.37 (0.10, 0.74) 0.34 (0.23, 0.47)
Achilles tendon 0.3 (0.12, 0.54) 0.75 (0.60, 0.85) 1.2 (0.52, 2.72) 0.68 (0.43, 0.86) 0.26 (0.15, 0.40)
Plantar fascia 0.15 (0.02, 0.46) 0.94 (0.84, 0.98) 3.02 (0.56, 16.32) 0.6 (0.17, 0.92) 0.16 (0.08, 0.27)
All sites 0.16 (0.11, 0.23) 0.86 (0.81, 0.90) 1.24 (0.79, 1.96) 0.56 (0.43, 0.68) 0.37 (0.32, 0.42)
TABLE 5 The sensitivity, specificity, LR, FPR and FNR of clinical examination for the presence of PDUS abnormalities
with vascularization
Entheseal site
Sensitivity
(95% CI)
Specificity
(95% CI) LR+ (95% CI) FPR (95% CI) FNR (95% CI)
Lateral epicondyle 0.3 (0.08, 0.64) 0.83 (0.71, 0.91) 1.86 (0.61, 5.6) 0.76 (0.45, 0.93) 0.11 (0.05, 0.23)
Great trochanter 1 (0.05, 1) 0.78 (0,67, 0,87) 4.73 (3,01, 7,41) 0.93 (0.67, 0.99) 0 (0, 0.07)
Quadriceps tendon 0.2 (0.01, 0.70) 0.97 (0.88, 0.99) 6.7 (0.72, 61.8) 0.66 (0.12, 0.98) 0.05 (0.01, 0.14)
Tibial tuberosity 0 (0, 0.60) 0.88 (0.77, 0.94) 0 (0, NaN) 1 (0.59, 1) 0.06 (0.02, 0.16)
Achilles tendon 0.16 (0, 0.63) 0.72 (0.60, 0.82) 0.61 (0.09, 3.81) 0.94 (0.71, 0.99) 0.09 (0.03, 0.21)
Plantar fascia NaN (NaN, NaN) 0.93 (0.83, 0.97) NaN (NaN, NaN) 1 (0.46, 1) 0 (0, 0.06)
All sites 0.23 (0.09, 0.44) 0.85 (0.81, 0.88) 1.61 (0.76, 3.38) 0.9 (0.8, 0.96) 0.05 (0.03, 0.08)
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[28]. Our study showed that the US abnormalities most
commonly found were enthesophytes (31.7%), calcifica-
tions (33.7%), thickening (29.8%) and hypoechogenicity
(26.6%), but these findings are not specific for AS. On
the other hand, we found erosions at the level of the
entheseal organ complex, strongly suggestive of AS, in
9.7% of examined entheseal sites. This result agrees
with the prevalence (6.3%) reported previously [5].
Furthermore, we found that the prevalence (6%) of the
PD signal at the level of examined entheseal sites was
lower than that of a previous study, reporting a PD
signal in 81% of abnormal enthesis [6]. In our study, the
high percentage of patients treated with anti-TNF-a drugs
could explain this discrepancy.
Finally, the age of our AS patients showing PDUS
abnormalities with vascularization was significantly higher
than the age of patients showing PDUS abnormalities with-
out vascularization. This observation agrees with Peers
et al. [29], showing a positive correlation between PDUS
and age in patients with chronic Achilles tendinopathy,
suggesting a possible role of repeated microtrauma in the
development of entheseal neo-vascularization. Although it
is well demonstrated that anti-TNF-a treatments reduce
enthesitis in SpA, we found that PDUS abnormalities
were not significantly different between patients treated
with or without anti-TNF-a drugs. Nevertheless, these re-
sults do not permit us to assess the efficacy of anti-TNF
drugs on enthesitis, because this cross-sectional study
was not designed to assess their efficacy.
Another interesting aspect of our study is the discrep-
ancy between entheseal abnormalities evaluated clinically
and by US. In fact, this aspect is not surprising because
enthesopathies could be asymptomatic [20] and US de-
tects more entheseal abnormalities than clinical examin-
ation [5, 6]. On the other hand, 46.8% of positive
entheseal sites by clinical examination did not show any
PDUS changes. These results agree with previous results
showing a considerable discrepancy between clinical and
US findings [5, 6]. Moreover, Alcalde et al. [20] found
normal US images in symptomatic entheses with a re-
markable dissociation between sensitivity to local pres-
sure and US findings. For explaining this dissociation, it
has been suggested that structures in proximity, such as
bone marrow, rather than the enthesis itself, could ac-
count for the pain [30].
In our study, taking PDUS as the gold standard, clinic-
al examination showed a low sensibility for the PDUS
presence of entheseal abnormalities with vascularization
(23%), entheseal abnormalities without vascularization
(16%) and entheseal erosions (21%) in all examination
sites. Instead, the specificity of clinical examination was
high for the PDUS presence of abnormalities with vascu-
larization (85%), abnormalities without vascularization
(86%) and erosions (85%). This low sensitivity and high
specificity of clinical examination agree with results of
Balint et al. [5], despite the fact that they used only
grey-scale US. Furthermore, the evidence of entheseal
abnormalities by clinical examination has a poor LR for
the presence of US abnormalities with vascularization
(LR = 1.61), without vascularization (LR = 1.24) and without
erosions (LR = 1.51) at all sites. Nevertheless, at single
sites, such as the patellar insertion of the quadriceps
tendon and tendon insertion at the great trochanter, the
evidence of entheseal abnormalities by clinical examin-
ation had a high LR for the presence of PDUS abnormal-
ities with vascularization (6.7 and 4.73, respectively),
suggesting the importance of the anatomy of a single
enthesis.
In our study, the discrepancy between clinical and
PDUS examinations has been further confirmed by slight
concordance using the weighted k-statistic. In fact,
k-values between clinical examination and US abnormal-
ities with vascularization, PDUS abnormalities without
vascularization and US erosion were 0.05, 0.03 and
0.05, respectively.
In conclusion, musculoskeletal US, a fast and relatively
inexpensive imaging tool, has an increasing and relevant
role in the assessment of peripheral entheseal involve-
ment in AS. In fact, PDUS permits detection of structural
and inflammatory abnormalities of the enthesis and may
complement physical examination in order to better evalu-
ate enthesitis.
Rheumatology key messages
. There is a discrepancy between AS peripheral en-
theseal involvement evaluated clinically and by US.
. PDUS detects structural and inflammatory abnorm-
alities of the enthesis and may complement phys-
ical examination.
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